PRECISION BIOSCIENCES INC Income Statement
DTIL|7 years of annual SEC 10-K data (FY2019-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 7 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Revenue
$69M
FY2025
Gross Profit
N/A
FY2025
Operating Income
-$26M
FY2025
Net Income
$7M
FY2025
PRECISION BIOSCIENCES INC reported $69M in revenue and $7M in net income for FY2025. Revenue has declined at a 36.7% compound annual rate over the past 6 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Accrual-heavy earnings: Net income significantly exceeds operating cash flow
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $68.7M | $48.7M | $25.1M | $115.5M | $24.3M | $22.2M | $1.1B |
| SG&A Expense | $35.3M | $39.1M | $41.3M | $39.7M | $36.1M | $27.0M | $13.7M |
| R&D Expense | $59.6M | $53.4M | $46.1M | $115.2M | $98.1M | $82.4M | $45.1M |
| Operating Income | -$26.2M | -$43.7M | -$62.3M | -$39.4M | -$109.8M | -$87.2M | -$47.9M |
| Interest Expense | - | $2.2M | $1.1M | $132.0K | $132.0K | $182.0K | $182.0K |
| Income Tax | $0 | - | - | - | $23.0K | $23.0K | - |
| Net Income | $7.2M | -$61.3M | -$111.6M | -$30.6M | -$109.0M | -$92.9M | -$46.0M |
| EPS (Basic) | $1.05 | -$15.96 | -$38.10 | -$0.52 | - | - | - |
| EPS (Diluted) | $1.04 | -$15.96 | -$38.10 | -$0.52 | -$2.09 | -$2.21 | -$2.92 |
| Shares Outstanding | 8.2M | 4.2M | 3.7M | 60.9M | 52.7M | 51.2M | 15.9M |
| Operating Margin | -38.1% | -89.8% | -248.3% | -34.1% | -452.3% | -392.1% | -4.5% |
| Profit Margin | 10.4% | -125.8% | -444.8% | -26.5% | -448.9% | -417.6% | -4.3% |